A39.9 Meningococcal infection, unspecified

Name of the Condition

• Meningococcal infection, unspecified

Summary

Meningococcal infection, unspecified, refers to a bacterial infection caused by Neisseria meningitidis without specification of the clinical presentation (e.g., meningitis, septicemia, or other manifestations). The condition can progress rapidly and requires prompt medical evaluation due to potential for severe outcomes.

Causes

Meningococcal infection is caused by the bacterium Neisseria meningitidis. Transmission occurs through respiratory droplets or direct contact with secretions from an infected person. The bacteria may colonize the nasopharynx before invading the bloodstream or central nervous system.

Risk Factors

• Close or prolonged contact with an infected individual (e.g., household members, roommates).
• Living in crowded settings (e.g., dormitories, military barracks).
• Travel to regions with high rates of meningococcal disease.
• Lack of vaccination against meningococcal disease.
• Certain medical conditions (e.g., complement deficiencies, asplenia).

Symptoms

• Sudden high fever.
• Severe headache.
• Stiff neck.
• Nausea and vomiting.
• Sensitivity to light (photophobia).
• Confusion or altered mental status.
• Skin rash (may appear as small, dark red or purple spots).

Diagnosis

Diagnosis involves clinical evaluation and laboratory testing. A lumbar puncture (spinal tap) may be performed to analyze cerebrospinal fluid, and blood cultures can identify the causative bacterium. Imaging or other tests may be used to assess complications.

Treatment Options

Treatment typically includes intravenous antibiotics (e.g., ceftriaxone or penicillin) to target Neisseria meningitidis. Supportive care, such as fluids and medications to manage shock or seizures, may be necessary. Close contacts may require prophylactic antibiotics.

Prognosis and Follow-Up

Prognosis depends on the severity of infection and timeliness of treatment. Early intervention improves outcomes, but severe cases can lead to long-term complications (e.g., hearing loss, limb loss) or death. Follow-up care may include monitoring for sequelae and rehabilitation as needed.

Complications

• Septic shock.
• Disseminated intravascular coagulation (DIC).
• Organ failure (e.g., kidney, adrenal glands).
• Neurological damage (e.g., seizures, cognitive impairment).
• Limb or tissue loss due to ischemia.

Lifestyle & Prevention

• Vaccination against meningococcal disease is recommended for high-risk groups.
• Avoid close contact with infected individuals during outbreaks.
• Practice good hygiene (e.g., handwashing) to reduce transmission risk.
• Seek prompt medical care for symptoms suggestive of infection.

When to Seek Professional Help

Seek immediate medical attention if experiencing sudden high fever, severe headache, stiff neck, or a rash with small dark spots, as these may indicate meningococcal infection. Early treatment is critical to reduce complications.

Tips for Medical Coders

Use A39.9 for cases of meningococcal infection where the specific clinical manifestation (e.g., meningitis, septicemia) is not documented. Ensure documentation supports the unspecified nature of the infection. Verify that other codes (e.g., for complications) are applied separately if applicable.